Abstract:The mechanistic target of rapamycin complex 1 (mTORC1) that regulates cellular gene and protein programming through its downstream signaling components the S6‐kinase and the ribosomal S6 protein serves as an intracellular energy sensor. Emerging evidence points to mTORC1 signaling as an important regulator of cardiovascular function with implications in hypertension. In this study, we tested the hypothesis that endothelial mTORC1 signaling is critically involved in the regulation of vascular endothelial function and that dysregulation of this pathway contributes to endothelial dysfunction. To test this, we generated mice bearing endothelial‐specific mTORC1 disruption by deleting the gene that encodes Raptor, an essential subunit of the complex. For this, we crossed tamoxifen‐inducible endothelial‐specific Cre mice (TekCreERT2) with mice harboring floxed alleles of the Raptor gene. Upon tamoxifen treatment, TekCreERT2/RaptorF/F mice exhibited ~60% reduction in total Raptor expression in endothelial cells (1.0±0.1 vs 0.4±0.1 AU; p<0.05) with no change in Raptor expression in smooth muscle cells (0.8±0.1 vs 1.0±0.1 AU). Tamoxifen treated TekCreERT2/RaptorF/F mice displayed reduced acetylcholine‐mediated endothelial (Max relax: 61±7 vs 34±11%; p<0.05) but not SNP‐induced smooth muscle vasorelaxation responses (Max relax: 84±2 vs 82±3%) in the aorta compared to tamoxifen‐treated wildtype littermates. To demonstrate the importance of mTORC1 signaling in this reduced acetylcholine‐mediated endothelial response in the aorta, we infected TekCreERT2/RaptorF/F aortic rings with an adenoviral S6‐kinase constitutively active construct (Ad‐S6KCA; 24hrs) to restore mTORC1 signaling. Infection with Ad‐S6KCA improved acetylcholine‐mediated endothelial vasorelaxation responses approaching wildtype control levels (Max relax: 54±6 vs 31±10%; p<0.05). We next assessed the effect of heterozygous deletion of endothelial Raptor in mice (TekCreERT2/RaptorF/+). Aortic rings from TekCreERT2/RaptorF/+ displayed intact acetylcholine‐induced vasorelaxation responses compared to tamoxifen‐treated wildtype controls (Max relax: 50±3 vs 49±8%). We next challenged aortic rings from tamoxifen treated TekCreERT2/RaptorF/+ mice with angiotensin II (100nM; 24hrs) to induce endothelial dysfunction. Angiotensin II incubation reduced acetylcholine‐mediated vasorelaxation responses of aortic rings from wildtype mice compared to vehicle (PBS) (Max relax: 57±4 vs 3±8%; p<0.05). Interestingly, aortic rings of TekCreERT2/RaptorF/+ mice treated with tamoxifen were partially protected from the endothelial dysfunction evoked by angiotensin II (Max relax: 3±8 vs 36±9%; p<0.05) indicating that mTORC1 signaling is critical for the vascular effects of angiotensin II. Our data indicate that endothelial mTORC1 signaling is required for the regulation of endothelial function and highlight the need for coordinated balance of mTORC1 signaling for endothelial homeostasis. We speculate that the endothelial mTORC1 signaling pathway may represent a novel target for cardiovascular risks associated with endothelial dysfunction such as hypertension.This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Abstract 442: Cardiomyocyte Specific mTORC1 Deletion Precipitates Interstitial Fibrosis, Heart Failure And Loss Of Female Cardio Protection

Mammalian target of rapamycin is essential for cardiomyocyte survival and heart development in mice.

mTOR inactivation in myocardium from infant mice rapidly leads to dilated cardiomyopathy due to translation defects and p53/JNK-mediated apoptosis

Mtorc1 and Mtorc2 Play Different Roles in Regulating Cardiomyocyte Differentiation from Embryonic Stem Cells.

Cardiac-Specific Suppression of Valosin-Containing Protein Induces Progressive Heart Failure and Premature Mortality Correlating with Temporal Dysregulations in mTOR Complex 2 and Protein Phosphatase 1

Abstract 067: Endothelial Mtorc1 Signaling Regulates Vascular Function and Mediates Angiotensin II Actions

Endothelial Mtorc1 Signaling is Required for Vascular Endothelial Function

Female Specific Restrictive Cardiomyopathy and Metabolic Dysregulation in transgenic mice expressing a Peptide of the Amino-Terminus of GRK2

Skeletal Muscle-Specific Ablation of raptor, but Not of rictor, Causes Metabolic Changes and Results in Muscle Dystrophy

Sex-specific cardiovascular remodeling leads to a divergent sex-dependent development of heart failure in aged hypertensive rats

MTOR INHIBITOR IMPROVES TESTOSTERONE-INDUCED MYOCARDIAL HYPERTROPHY IN HYPERTENSIVE RATS.

Hyperactive mTORC1/4EBP1 Signaling Dysregulates Proteostasis and Accelerates Cardiac Aging.

Oxidative stress and inflammation distinctly drive molecular mechanisms of diastolic dysfunction and remodeling in female and male heart failure with preserved ejection fraction rats

Hyperactivation of mTOR and AKT in a cardiac hypertrophy animal model of Friedreich ataxia

Phosphoinositide-Dependent Kinase 1 And Mtorc2 Synergistically Maintain Postnatal Heart Growth And Heart Function In Mice

Hyperactive mTORC1/4EBP1 signaling dysregulates proteostasis and accelerates cardiac aging

Differential Response of Skeletal Muscles to Mtorc1 Signaling During Atrophy and Hypertrophy

Alterations to Mtorc1 Signaling in the Skeletal Muscle Differentially Affect Whole-Body Metabolism.

mTOR-mediated calcium transients affect cardiac function in ex vivo ischemia-reperfusion injury

STUDY ON THE MECHANISM OF CARDIAC HYPERTROPHY INDUCED BY TESTOSTERONE THROUGH MTORC2 IN OVARIECTOMIZED FEMALE SPONTANEOUSLY HYPERTENSIVE RATS

Abstract 4129520: the Mechanism of Cardiac Hypertrophy Induced by Testosterone in Postmenopausal Women Through the Activation of the Mtorc2/atg9a